skinny.

Latest / Stock Movers

NatWest Rises, Sanofi Climbs, Saab Surges

On this episode of Stock Movers:

- NatWest raised its guidance for the year after beating estimates in the 3Q, delivering its highest earnings in at least a decade.

- Sanofi’s profit rose more than analysts expected last quarter, lifted by demand for its blockbuster skin and asthma drug Dupixent.

- Saab boosted its organic revenue forecast for the full year, benefiting from the uncertainty of the geopolitical landscape, adding it's received a record high order backlog.

See omnystudio.com/listener for privacy information.

Log in to save or queue this episode.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.